- A recombinant vaccine antigen is produced as a fusion protein in yeast. The antigen is immunogenic in animals, but a subset of batches shows reduced antibody titers. Analysis suggests variable proteolytic cleavage of the fusion protein during production.
Which outcome is most consistent with this biotechnological application?
Answer: Proteolytic cleavage could reduce the amount of intact antigen presented, lowering immunogenicity across batches.
The skill being tested is quality control in recombinant vaccine production using biotechnology. Proteolytic cleavage during production can degrade antigens, reducing immunogenicity and causing batch variability. In this scenario, some batches show lower antibody titers, linked to variable cleavage. Choice C is correct because cleavage reduces intact antigen, lowering immune responses. Choice B is incorrect because cleavage does not increase gene copy number. For similar questions, monitor post-translational stability. This ensures consistent vaccine efficacy across batches.
- Researchers clone a human cytokine cDNA into a bacterial expression plasmid under an inducible promoter. After transformation into E. coli, colonies are grown with and without inducer. Protein levels are assessed by SDS-PAGE and immunoblotting with an anti-cytokine antibody.
Observation: A strong cytokine band appears only in induced cultures of transformed bacteria; no cytokine band appears in uninduced cultures or in induced cultures transformed with empty vector.
Which outcome is most consistent with the use of gene cloning in this context?
Answer: Induction activates transcription from the plasmid promoter, increasing cytokine production in transformed cells.
The skill being tested is gene cloning and inducible expression systems in recombinant DNA and biotechnology for protein production. Inducible promoters in plasmids allow controlled transcription of cloned genes in host cells like E. coli upon addition of an inducer. In this scenario, the human cytokine cDNA is cloned into a bacterial plasmid, and immunoblotting shows the cytokine band only in induced transformed cultures, absent in uninduced or empty vector controls. Choice B is correct because induction activates the promoter, leading to transcription and production of the cytokine specifically in cells with the recombinant plasmid. Choice A is incorrect because plasmids typically replicate independently, not integrating into the chromosome for constitutive expression. For similar questions, confirm expression specificity by comparing induced versus uninduced conditions. This approach verifies successful cloning and helps troubleshoot expression issues in biotechnology.
- A clinician orders a PCR test to detect a low-abundance bacterial DNA target in cerebrospinal fluid. To improve detection, the lab increases the number of amplification cycles substantially beyond its validated protocol. After the change, more samples test positive, but several positives occur in patients with low clinical suspicion and negative cultures.
Which result would be expected if excessive PCR cycling is the main cause of the unexpected positives in this context?
Answer: An increased rate of nonspecific amplification and detection of trace contaminant DNA, raising false-positive results
This question tests understanding of how excessive PCR cycling affects assay specificity in clinical diagnostics. PCR amplification is exponential, but as cycle numbers increase beyond optimal ranges, primer-dimers and non-specific products begin to accumulate, especially when target DNA is scarce or absent. In this clinical scenario, increasing cycles beyond the validated protocol led to more positive results in patients with low clinical suspicion, suggesting false positives from amplification of trace contaminants or non-specific sequences. The correct answer recognizes that excessive cycling reduces specificity and increases false-positive rates by allowing weak, non-specific interactions to generate detectable products. Choice B incorrectly claims polymerase activity drops to zero, while choice C wrongly suggests more cycles improve specificity. In clinical PCR, cycle number optimization balances sensitivity with specificity - too few cycles miss true positives, but too many cycles generate false positives from background amplification.
- A forensic lab performs PCR amplification of a short tandem repeat (STR) locus from trace DNA. The sample is highly degraded, and the lab can choose between two primer pairs: Pair X amplifies a 120-bp fragment; Pair Y amplifies a 380-bp fragment spanning the same STR region. All other conditions are identical. The lab wants the highest likelihood of obtaining an interpretable STR profile.
Which outcome is most consistent with PCR performance on degraded DNA in this context?
Answer: Pair X is more likely to amplify successfully because shorter targets are more likely to remain intact in degraded samples
This question tests understanding of PCR performance on degraded DNA templates in forensic biotechnology applications. DNA degradation causes random breaks in the template strands, and the probability of having an intact template spanning the entire amplicon decreases with target length. In this forensic scenario with highly degraded DNA, the shorter 120-bp target (Pair X) has a much higher likelihood of finding intact template molecules compared to the 380-bp target (Pair Y), even though both span the same STR region. The correct answer recognizes this fundamental principle of PCR on degraded samples - shorter amplicons are more likely to amplify successfully because they require less intact template DNA. Choice A incorrectly suggests longer targets amplify better, contradicting established forensic practice. For degraded DNA samples in forensic or ancient DNA work, always design the shortest possible amplicons that still capture the necessary genetic information to maximize amplification success.
- A lab constructs a plasmid to express a recombinant bacterial antigen for use in a subunit vaccine candidate. After transformation, colonies are screened by digesting isolated plasmid DNA with two restriction enzymes that cut once on either side of the insertion site in the vector. Some colonies yield a single linear band consistent with empty vector length; others yield a larger band consistent with vector plus insert.
Which outcome is most consistent with using restriction digest screening in this cloning context?
Answer: Colonies with the larger band are more likely to contain the antigen insert because the digest releases a plasmid length increased by the inserted DNA
This question tests understanding of restriction digest screening in molecular cloning workflows. When a DNA insert is successfully cloned between two restriction sites, the resulting plasmid will be larger by the size of the insert, producing a longer linear fragment upon digestion compared to empty vector. In this vaccine development scenario, colonies yielding the larger band contain the plasmid with the antigen gene insert, while those with the smaller band contain self-ligated empty vector without insert. The correct answer properly interprets that larger digest products indicate successful insertion of the antigen coding sequence. Choice B incorrectly relates plasmid size to promoter strength, while choice C confuses DNA analysis with protein characterization. Restriction digest screening remains a fundamental technique for rapidly identifying positive clones before proceeding to more expensive sequencing or expression analysis, making it an essential skill in recombinant DNA work.
- A hospital laboratory evaluates a PCR-based assay to detect a 210-bp segment of the toxA gene from a bacterial pathogen in sputum. Two primer sets are tested: Set 1 is fully complementary to conserved regions flanking the target; Set 2 has a single mismatch at the 3′ end of the forward primer (all other bases match). Samples are processed with identical cycling conditions and analyzed by endpoint fluorescence. In a pilot, culture-positive specimens yield strong signal with Set 1, while Set 2 yields weak or absent signal despite similar total DNA input. The lab wants to understand which outcome is most consistent with the use of PCR primers in this diagnostic context.
Which result would be expected if the 3′-mismatched primer set is used across additional true-positive specimens under the same conditions?
Answer: A higher fraction of true-positive specimens will fail to amplify because DNA polymerase extension is reduced when the primer 3′ end is mismatched
This question tests understanding of how primer-template mismatches affect PCR amplification efficiency in recombinant DNA applications. DNA polymerase requires proper base pairing at the 3' end of primers to initiate extension; mismatches at this critical position severely reduce or prevent polymerase activity. In this diagnostic scenario, Set 2's 3' mismatch on the forward primer would cause DNA polymerase to stall or dissociate rather than extend, resulting in minimal or no amplification of the toxA gene target. The correct answer recognizes that true-positive specimens (containing the pathogen) would fail to amplify with the mismatched primer set, reducing assay sensitivity. Choice B incorrectly suggests mismatches improve binding, when they actually destabilize primer-template interactions and reduce melting temperature. To verify primer design in PCR diagnostics, always check that the 3' ends of both primers are fully complementary to the target sequence, as even single mismatches can cause false-negative results.
- A research group clones a human cytokine cDNA into a bacterial expression plasmid downstream of an inducible promoter. The plasmid contains an antibiotic resistance gene and a multiple cloning site. After transformation into E. coli, colonies are selected on antibiotic plates and then induced to express the recombinant protein. Unexpectedly, many antibiotic-resistant colonies produce no detectable cytokine by immunoblot, even though plasmid DNA is present.
Which conclusion is most supported by gene cloning principles in this context?
Answer: Some colonies likely contain plasmids with inserts in the wrong orientation or reading frame, preventing productive translation of the cytokine
This question tests understanding of gene cloning outcomes and the relationship between antibiotic selection and recombinant protein expression. In bacterial expression systems, antibiotic resistance and target gene expression are typically controlled by separate genetic elements - the resistance gene has its own promoter while the cloned gene uses the inducible promoter. The scenario describes antibiotic-resistant colonies that fail to produce detectable cytokine, which commonly occurs when inserts are cloned in the wrong orientation (antisense) or out of frame with the start codon, preventing proper translation. The correct answer recognizes that successful plasmid uptake (conferring antibiotic resistance) doesn't guarantee proper insert orientation or reading frame for protein expression. Choice C incorrectly claims transformation requires cytokine expression, when these are independent processes. When screening recombinant clones, expect that some percentage will contain non-productive inserts despite successful transformation, requiring multiple colonies to be screened to identify those with correct insert orientation and frame.
- A diagnostic lab uses PCR to detect a viral DNA sequence in patient swabs. To reduce false positives from carryover contamination, the lab switches from dTTP to dUTP in PCR reactions and treats reaction mixes with uracil-DNA glycosylase (UDG) before amplification. The goal is to degrade contaminating PCR products from prior runs while preserving authentic viral DNA in new specimens.
Which outcome is most consistent with this PCR contamination-control strategy?
Answer: UDG will preferentially degrade any contaminating amplicons containing uracil, reducing false positives while leaving native viral DNA largely unaffected
This question tests understanding of contamination control strategies in PCR-based diagnostics using dUTP/UDG systems. The strategy exploits the fact that PCR products made with dUTP contain uracil instead of thymine, while natural DNA contains only thymine. Uracil-DNA glycosylase (UDG) specifically removes uracil bases from DNA, creating abasic sites that cause strand breaks during heating, preventing amplification of uracil-containing contaminants from previous reactions. Meanwhile, authentic viral DNA from patient samples contains thymine and remains unaffected by UDG treatment. The correct answer properly explains how UDG selectively degrades contaminating amplicons while preserving native DNA targets. Choice B incorrectly describes UDG function, and choice D confuses UDG with DNA polymerase. This dUTP/UDG system is widely used in clinical diagnostics to prevent false positives from PCR product carryover, a critical quality control measure in high-throughput testing environments.
- A cell biology lab uses CRISPR-Cas9 to knock out the gene SLC2A1 (GLUT1) in a human cancer cell line to test whether glucose uptake is required for rapid proliferation. After editing, single-cell clones are expanded and assessed by sequencing across the target site and by measuring uptake of a fluorescent glucose analog. Several clones show small insertions/deletions (indels) near the expected cut site, and these same clones show markedly reduced glucose analog uptake compared with parental cells.
Based on the scenario, which conclusion is most supported by the use of CRISPR-Cas9 in this context?
Answer: The reduced uptake is consistent with disruptive indels causing loss of functional GLUT1 protein in edited clones
This question tests understanding of CRISPR-Cas9 gene knockout mechanisms and their functional consequences in biotechnology applications. CRISPR-Cas9 creates double-strand breaks at target sites, which cells repair through error-prone non-homologous end joining (NHEJ), often introducing small insertions or deletions (indels) that disrupt the reading frame. In this scenario, indels in the SLC2A1/GLUT1 gene would cause frameshifts leading to premature stop codons or non-functional protein, explaining the reduced glucose uptake in edited clones. The correct answer properly connects the molecular mechanism (indels causing loss of functional GLUT1) with the phenotypic outcome (reduced glucose analog uptake). Choice B incorrectly attributes the effect to direct Cas9 activity on the glucose analog, while choice C misunderstands CRISPR's mechanism - without a repair template, CRISPR typically causes random indels, not precise mutations. To validate CRISPR knockouts, always confirm both genotype (sequencing showing indels) and phenotype (functional loss of the target protein's activity).
- Researchers use CRISPR-Cas9 to disrupt a tumor suppressor gene in a diploid human cell line. After editing and cloning, sequencing shows one allele contains a frameshift indel, while the other allele remains wild-type. The researchers measure protein levels and find the tumor suppressor protein is still detectable, though reduced compared with parental cells.
Which conclusion is most supported by these findings in the context of CRISPR knockout experiments?
Answer: The clone is likely a heterozygous edit, so residual protein expression can persist from the unedited allele
This question tests understanding of CRISPR outcomes in diploid cells and the importance of targeting both alleles for complete knockouts. In diploid human cells, each gene has two alleles, and CRISPR must successfully edit both to achieve complete loss of function. The scenario describes a heterozygous edit where one allele has a frameshift indel while the other remains wild-type, explaining why the tumor suppressor protein is still detectable but at reduced levels - the wild-type allele continues producing functional protein. The correct answer recognizes this common outcome in CRISPR experiments where incomplete editing leaves residual gene function. Choice B incorrectly claims any edit affects both alleles, while choice C misunderstands CRISPR's nuclear targeting. For complete knockouts in diploid cells, researchers must screen for clones with biallelic edits or use selection strategies that enrich for complete loss of function, as heterozygous edits often retain partial activity.
- A biotech company develops a recombinant monoclonal antibody intended to neutralize a circulating inflammatory cytokine in patients. During preclinical testing, the antibody binds the cytokine with high affinity in vitro, but in vivo efficacy is poor. Pharmacokinetic analysis shows rapid clearance from circulation compared with an otherwise similar antibody used clinically.
Which modification is most consistent with recombinant protein engineering approaches to improve in vivo half-life in this context?
Answer: Engineering the Fc region to enhance neonatal Fc receptor (FcRn) recycling and reduce lysosomal degradation
This question tests understanding of recombinant antibody engineering strategies to improve pharmacokinetic properties in therapeutic applications. The Fc region of antibodies contains binding sites for the neonatal Fc receptor (FcRn), which protects antibodies from degradation by recycling them from endosomes back to circulation rather than allowing lysosomal degradation. The scenario describes rapid clearance of a therapeutic antibody, suggesting poor FcRn interaction, which can be improved by engineering mutations in the Fc region that enhance FcRn binding at acidic pH. The correct answer identifies this established biotechnology approach for extending antibody half-life in vivo. Choice A would destabilize the antibody structure, choice C misunderstands that antibodies must be produced in appropriate expression systems before administration, and choice D confuses restriction sites with binding specificity. When developing therapeutic antibodies, Fc engineering for enhanced FcRn binding is a standard approach to improve pharmacokinetics and reduce dosing frequency.
- A lab uses PCR to genotype a single-nucleotide variant (SNV) associated with drug metabolism. Primers amplify a 120-bp region containing the SNV. The PCR product is then sequenced. One patient's chromatogram shows overlapping peaks (A and G) at the SNV position.
Which result would be expected if PCR is being applied correctly in this context?
Answer: The patient is likely heterozygous at the SNV locus, yielding mixed base calls at that position.
The skill being tested is PCR-based genotyping of single-nucleotide variants in recombinant DNA analysis. Sanger sequencing of PCR products can reveal heterozygosity as overlapping peaks at polymorphic sites. In this scenario, the patient's chromatogram shows A and G peaks at the SNV position in the 120-bp amplicon. Choice A is correct because overlapping peaks indicate heterozygosity, with both alleles amplified. Choice C is incorrect because PCR targets DNA, not protein, and primers anneal to DNA templates. For similar questions, inspect chromatograms for peak overlaps. This method ensures accurate variant calling in pharmacogenomics.
- A lab clones a eukaryotic gene into a plasmid for expression in E. coli to produce a recombinant enzyme for a metabolic disorder. The team initially inserts the gene directly from human genomic DNA (including introns) into a bacterial expression vector and observes no functional enzyme activity in lysates, despite antibiotic-resistant growth and plasmid maintenance.
Which result would be expected if the team instead clones a cDNA version of the gene (derived from mature mRNA) into the same bacterial vector?
Answer: Functional enzyme activity is more likely because cDNA lacks introns that bacteria generally cannot splice out
This question tests understanding of why cDNA cloning is necessary for expressing eukaryotic genes in bacterial systems. Bacteria lack the splicing machinery to remove introns from eukaryotic genes, so genomic DNA containing introns will produce mRNA with retained intron sequences that disrupt the coding sequence and prevent functional protein production. The scenario shows this exact problem - no functional enzyme despite successful transformation. Using cDNA, which is reverse-transcribed from mature mRNA and therefore lacks introns, provides a continuous coding sequence that bacteria can properly transcribe and translate into functional protein. The correct answer recognizes that cDNA enables functional expression because it lacks the introns that bacteria cannot process. Choice B incorrectly claims cDNA cannot be transcribed by bacteria, when bacterial RNA polymerase can transcribe any DNA under appropriate promoter control. When expressing eukaryotic proteins in bacteria, always use cDNA or synthetic genes without introns to ensure proper translation.
- A pharmaceutical team produces a recombinant human growth factor in E. coli for preclinical studies. The protein binds its receptor in vitro, but repeated dosing in animals triggers strong anti-drug antibodies. The team considers changing the production system.
Which outcome is most consistent with using a mammalian expression system for this recombinant protein?
Answer: The protein may acquire human-like post-translational modifications that can alter immunogenicity and pharmacokinetics.
The skill being tested is host system selection for recombinant protein production in biotechnology. Mammalian cells provide human-like post-translational modifications, potentially reducing immunogenicity compared to bacterial systems. In this scenario, E. coli-produced growth factor triggers antibodies, prompting a system change. Choice D is correct because mammalian modifications can improve tolerability and function. Choice B is incorrect because the DNA sequence remains unchanged. For similar questions, assess immunogenicity in animal models. This optimizes therapeutics for clinical use.
- A CRISPR-Cas9 knockout is performed to evaluate whether a transporter is required for uptake of a fluorescent drug analog. After editing, cells show reduced fluorescence compared with control cells. However, a subset of edited cells still shows high fluorescence. The lab suspects incomplete knockout in the population.
Which result would be expected if the observed heterogeneity is due to incomplete editing by CRISPR-Cas9?
Answer: Single-cell cloning would yield some clones with wild-type transporter sequence and others with disruptive indels.
The skill being tested is assessing CRISPR-Cas9 editing efficiency and heterogeneity in biotechnology. Incomplete editing results in mixed populations with varying genotypes, detectable by functional assays or sequencing. In this scenario, edited cells show overall reduced fluorescence, but some retain high levels, suggesting incomplete knockout. Choice D is correct because single-cell cloning would reveal wild-type and edited clones, explaining heterogeneity. Choice B is incorrect because CRISPR efficiency is not always 100%; variability occurs. For similar questions, quantify editing rates via sequencing. This ensures accurate interpretation of phenotypic screens.
- A researcher clones a bacterial toxin gene into a plasmid that includes an antibiotic resistance marker. After ligation and transformation, bacteria are plated on antibiotic-containing media. Hundreds of colonies grow. However, sequencing reveals that many colonies contain plasmid without the toxin insert.
Which outcome is most consistent with this gene cloning result?
Answer: Antibiotic selection confirms plasmid uptake but does not guarantee insertion of the toxin gene.
The skill being tested is plasmid-based gene cloning and selection in recombinant DNA techniques. Antibiotic selection ensures plasmid uptake but does not confirm the presence of the desired insert, as empty vectors can also confer resistance. In this scenario, many colonies grow on antibiotic media, but sequencing shows plasmids without the toxin gene insert. Choice C is correct because selection verifies transformation but not successful ligation of the insert. Choice B is incorrect because plasmids typically do not integrate into the chromosome; they replicate episomally. For similar questions, screen colonies by PCR or sequencing post-selection. This step optimizes cloning efficiency in biotechnology workflows.
- A lab performs PCR on DNA extracted from formalin-fixed paraffin-embedded (FFPE) tumor tissue to detect a 600-bp mutation-containing region. No product is observed. When the lab repeats PCR targeting a 120-bp region, a clear band appears.
Which conclusion is most supported by the use of PCR in this context?
Answer: FFPE DNA is often fragmented, so shorter amplicons are more likely to amplify successfully.
The skill being tested is PCR amplification from degraded DNA samples in biotechnology. Fragmented DNA, like in FFPE, favors shorter amplicons, as longer templates are often broken. In this scenario, the 600-bp PCR fails, but 120-bp succeeds. Choice D is correct because fragmentation hinders long amplicon formation. Choice B is incorrect because longer amplicons do not amplify better in degraded samples. For similar questions, design short amplicons for degraded DNA. This improves mutation detection in archival tissues.
- A researcher uses CRISPR-Cas9 to edit a single base in a gene associated with an inherited disease, aiming to restore the wild-type sequence in patient-derived cells. After editing, sequencing shows both corrected alleles and unedited alleles in the population.
Which result would be expected if the edited cells are not clonally isolated before analysis?
Answer: Bulk sequencing can show a mixture of corrected and uncorrected sequences due to a heterogeneous cell population.
The skill being tested is analyzing CRISPR-Cas9 editing in heterogeneous populations for biotechnology applications. Bulk sequencing reveals mixed alleles if editing is incomplete, showing both edited and unedited sequences. In this scenario, sequencing post-editing shows corrected and unedited alleles without clonal isolation. Choice D is correct because non-clonal populations yield mixed signals. Choice B is incorrect because editing is not always uniform. For similar questions, perform clonal expansion for pure genotypes. This ensures precise evaluation of base editing outcomes.
- A company develops a recombinant enzyme replacement therapy produced in CHO cells. In vitro assays confirm enzymatic activity, but patient dosing requires high amounts due to rapid clearance from circulation. The team considers modifying the recombinant product to increase half-life.
Which outcome is most consistent with a strategy that increases circulating half-life of a recombinant therapeutic protein?
Answer: Fusing the enzyme to an Fc domain to leverage recycling pathways and reduce clearance.
The skill being tested is engineering recombinant proteins to improve pharmacokinetics in biotechnology. Fusing proteins to Fc domains extends half-life by engaging neonatal Fc receptor-mediated recycling, reducing clearance. In this scenario, the CHO-produced enzyme shows activity but rapid clearance, prompting half-life modifications. Choice B is correct because Fc fusion leverages endogenous pathways to prolong circulation. Choice C is incorrect because E. coli lacks human glycosylation, potentially worsening pharmacokinetics. For similar questions, evaluate fusion strategies for therapeutic impact. This approach enhances drug efficacy in enzyme replacement therapies.
- A lab clones a gene into a plasmid with a strong promoter and ribosome binding site to overexpress the protein in bacteria. After induction, the target protein accumulates mostly in insoluble fractions, while little is found in the soluble lysate.
Which outcome is most consistent with gene cloning for bacterial overexpression in this context?
Answer: Overexpression can lead to inclusion body formation, reducing soluble protein despite high total expression.
The skill being tested is bacterial overexpression of recombinant proteins using plasmids in biotechnology. High expression can lead to insoluble inclusion bodies, sequestering protein from soluble fractions. In this scenario, the protein is mostly insoluble post-induction despite strong promoter use. Choice D is correct because overexpression often causes aggregation into inclusion bodies. Choice B is incorrect because insolubility does not indicate ligation failure; expression occurred. For similar questions, optimize induction conditions to enhance solubility. Tags or chaperones can aid in recovering functional protein.
